Concepts represent early planning stages for program announcements, requests for applications, or solicitations for Council's input. If NIAID publishes an initiative from one of these concepts, we link to it below. To find initiatives, go to Opportunities & Announcements.
NB: Council approval does not guarantee that a concept will become an initiative.
Table of Contents
- Collaborative Influenza Vaccine Innovation Centers (CIVIC)
- Leadership Group for an Infectious Diseases Clinical Research Consortium
- Vaccine and Treatment Evaluation Units (VTEUs)
- Leadership Group for a Clinical Research Network on Antibacterial Resistance
- Accelerating Malaria Vaccine Discovery
- Advancing Research Needed To Develop a Universal Influenza Vaccine
- Control of Sexually Transmitted Infections (STIs) Through a Comprehensive Understanding of the Natural History of Infection
- Research To Advance Vaccine Safety
- Secondary Analysis of Existing Datasets for Advancing Infectious Disease Research
Collaborative Influenza Vaccine Innovation Centers (CIVIC)
For the published broad agency announcement, see the June 1, 2018 solicitation, 2018 NIAID Omnibus Broad Agency Announcement and the July 3, 2018 Amendment 1, Collaborative Influenza Vaccine Innovation Centers (CIVIC). For the published request for proposals, see the August 31, 2018 solicitation, CIVICs Statistical, Data Management and Coordination Center (SDMCC).
Leadership Group for an Infectious Diseases Clinical Research Consortium
For the published request for applications, see the October 1, 2018 Guide announcement, Leadership Group for an Infectious Diseases Clinical Research Consortium (IDCRC) (UM1 Clinical Trial Required).
Vaccine and Treatment Evaluation Units (VTEUs)
For the published request for applications, see the October 1, 2018 Guide announcement, Vaccine and Treatment Evaluation Units (VTEUs) (UM1 Clinical Trial Required).
Leadership Group for a Clinical Research Network on Antibacterial Resistance
For the published request for applications, see the July 9, 2018 Guide announcement, Leadership Group for a Clinical Research Network on Antibacterial Resistance (UM1, Clinical Trial Required).
Accelerating Malaria Vaccine Discovery
For the published program announcement, see the November 26, 2018 Guide announcement, Accelerating Malaria Vaccine Discovery (R01 Clinical Trial Not Allowed).
Advancing Research Needed To Develop a Universal Influenza Vaccine
For the published program announcements, see the July 18, 2018 Guide announcements:
- Advancing Research Needed to Develop a Universal Influenza Vaccine (R21, Clinical Trial Not Allowed)
- Advancing Research Needed to Develop a Universal Influenza Vaccine (R01, Clinical Trial Not Allowed)
Control of Sexually Transmitted Infections (STIs) Through a Comprehensive Understanding of the Natural History of Infection
For the published program announcement, see the November 29, 2018 Guide announcement, Control of Sexually Transmitted Infections (STIs) Through a Comprehensive Understanding of the Natural History of Infection (R01 Clinical Trial Not Allowed).
Research To Advance Vaccine Safety
For the published program announcements, see the July 24, 2018 Guide announcements:
- Research To Advance Vaccine Safety (R21 Clinical Trial Not Allowed)
- Research To Advance Vaccine Safety (R01 Clinical Trial Not Allowed)
Secondary Analysis of Existing Datasets for Advancing Infectious Disease Research
For the published program announcement, see the November 13, 2018 Guide announcement, Secondary Analysis of Existing Datasets for Advancing Infectious Disease Research (R21 Clinical Trial Not Allowed).